IP Library › Patent Application 17140206
Patent Application
App. No. 17/140,206

SUBSTITUTED TETRACYCLINE COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/140,206
Abstract

The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.

Claims (10)

1 - 391 . (canceled)

392 . A method for treating a tetracycline responsive state in a subject, comprising administering to said subject an effective amount of a tetracycline compound of formula (VIIA):

wherein:

X is CR 6 *CR 6*′ ;

R 5*′ is hydrogen;

R 5*′ is hydrogen or hydroxyl;

R 6*′ is hydrogen or alkyl;

R 6*′ is hydrogen;

R 7′ is alkylamino; and

R 9m* is oxazolyl or isoxazolyl or a pharmaceutically acceptable salt thereof, such that said subject is treated.

Assignments (2)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 065001/0917 Recorded May 22, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 071343/0407 →
SECURITY INTEREST Recorded Sep 22, 2023
From: PARATEK PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 065001/0917 →